{"task_id": "ff362fb880bbbf61", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 18/464)", "text": "n and\nmechanical ventilation\n2\nAsthma Exacerbation\n\n--- Page 24 ---\nSPECIFIC ENTITIES\nEXERCISE INDUCED ASTHMA\n\u0002\nPATHOPHYSIOLOGY\nmildasthma with symptoms only\nduringexerciseduetobronchoconstrictionasaresultof\ncooling of airways associated with heat and water loss\n\u0002\nDIAGNOSIS\nspirometry. Exercise or methacholine\nchallenge may help in diagnosis\n\u0002\nTREATMENTS\nprophylaxis with salbutamol 2 puffs,\ngiven 5 10 min before exercise. Consider leuko\ntriene antagonists or inhaled glucocorticoids if\nfrequent use of prophylaxis\nTRIAD ASTHMA (Samter\u2019s syndrome)\ntriad of\nasthma, aspirin/NSAIDs sensitivity, and nasal polyps.\nCyclooxygenase inhibition ! # prostaglandin E2 ! \"\nleukotriene synthesis ! asthma symptoms. Manage\nment include ASA/NSAIDs avoidance and leukotriene\nantagonists (montelukast)\nSPECIFIC ENTITIES (CONT\u2019D)\nALLERGIC BRONCHOPULMONARY ASPERGILLOSIS\n(ABPA)\n\u0002\nPATHOPHYSIOLOGY\nassociated withasthma and cys\ntic fibrosis. Due to colonization of the airways by\nAspergillus fumigatus, leading to an intense, immedi\nate hypersensitivity type reaction in the airways\n\u0002\nCLINICAL FEATURES\nhistory of asthma, recurrent epi\nsodes of fever, dyspnea, and productive cough\n(brownish sputum). Peripheral eosinophilia. CXR find\nings of patchy infiltrates and central bronchiectasis\n\u0002\nDIAGNOSIS\nabove clinical features plus Aspergillus\nextract skin test, serum IgE level, sputum for Asper\ngillus and/or serologic tests (IgE and IgG against\nAspergillus)\n\u0002\nTREATMENTS\nsystemic glucocorticoids, itraconazole\nCOPD Exacerbation\nNEJM 2004 250:26\nDIFFERENTIAL DIAGNOSIS OF ACUTE DYSPNEA\nRESPIRATORY\n\u0002\nAIRWAY\nCOPD exacerbation, asthma exacerba\ntion, acute bronchitis, infectious exacerbation of\nbronchiectasis, foreign body obstruction\n\u0002\nPARENCHYMA\npneumonia, cryptogenic organiz\ning pneumonia, ARDS, acute exacerbation of\ninterstitial lung disease\n\u0002\nVASCULAR\npulmonary\nembolism,\npulmonary\nhypertension\n\u0002\nPLEURAL\npneumothorax, pleural effusion\nCARDIAC\n\u0002\nMYOCARDIAL\nHF\nexacerbation,\nmyocardial\ninfarction\n\u0002\nVALVULAR\naortic stenosis, acute aortic regurgi\ntation, mitral stenosis, endocarditis\n\u0002\nPERICARDIAL\npericardial effusion, tamponade\nSYSTEMIC\nsepsis, metabolic acidosis, anemia\nOTHERS\nneuromuscular, psychogenic, anxiety\nPATHOPHYSIOLOGY\nPRECIPITANTS OF COPD EXACERBATION\ninfec\ntions, lifestyle/environmental (10%, cigarette smoke,\ndust, pollutants, cold air), non adherence, pulmonary\nembolism, pulmonary edema, pneumothorax, progres\nsion of COPD\nCLINICAL FEATURES\nRATIONAL\nCLINICAL\nEXAMINATION\nSERIES:\nDOES THE CLINICAL EXAMINATION PREDICT\nAIRFLOW LIMITATION?\nSens Spc\nLR+ LR\nHistory\nSmoking >70 pack year\n40% 95%\n8\n0.63\nSmoking ever\n92% 49%\n1.8\n0.16\nCLINICAL FEATURES (CONT\u2019D)\nSens Spc\nLR+ LR\nSputum >1/4 cup\n20% 95%\n4\n0.84\nChronic bronchitis Sx\n30% 90%\n3\n0.78\nWheezing\n51% 84%\n3.8\n0.66\nAny exertional dyspnea\n27% 88%\n2.2\n0.83\nCoughing\n51% 71%\n1.8\n0.69\nAny dyspnea\n82% 33%\n1.2\n0.55\nPhysical\nWheezing\n15% 100% 36\n0.85\nBarrel chest\n10% 99%\n10\n0.90\nDecreased cardiac\ndullness\n13% 99%\n10\n0.88\nMatch test\n61% 91%\n7.1\n0.43\nRhonchi\n8%\n99%\n5.9\n0.95\nHyperresonance\n32% 94%\n4.8\n0.73\nFEV1 >9 s\n4.8\nFEV1 6 9 s\n2.7\nFEV1 <6 s\n0.45\nSubxyphoid cardiac apical\nimpulse\n8%\n98%\n4.6\n0.94\nPulsus paradoxus\n(>15 mmHg)\n45% 88%\n3.7\n0.62\nDecreased breath sounds 37% 90%\n3.7\n0.70\nAccessory muscle use\n24% 100%\n0.70\nAPPROACH\n\u2018\u2018no single item or combination of\nitems from the clinical examination rules out air\nflow limitation. The best findings associated with\nincreased likelihood of airflow limitation are objec\ntive wheezing, FEV1 >9 s, positive match test,\nbarrel chest, hyperresonance and subxyphoid car\ndiac impulse. Three findings predict the likelihood\nof airflow limitation in men: years of cigarette\nsmoking, subjective wheezing and either objective\nwheezing or peak expiratory flow rate\u2019\u2019\nJAMA 1995 273:4\nCOPD Exacerbation\n3", "text_length": 3793, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 18/464)", "type": "chunk", "chunk_index": 17, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.256441", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.257388", "status": "complete", "chunks_added": 2}